Development and Implementation of a High-Throughput Compound Screening Assay for Targeting Disrupted ER Calcium Homeostasis in Alzheimer's Disease

• Kamran Honarnejad,

  Current address: Institute of Pharmacology and Toxicology, University of Bonn, Germany

  Affiliations Department of Translational Brain Research, DZNE – German Center for Neurodegenerative Diseases, Munich, Germany, Center for Neuropathology and Prion Research; Ludwig Maximilian University, Munich, Germany, Graduate School of Systemic Neurosciences, Ludwig Maximilian University, Munich, Germany

  ⨯
• Alexander Daschner,

  Affiliations Department of Translational Brain Research, DZNE – German Center for Neurodegenerative Diseases, Munich, Germany, Center for Neuropathology and Prion Research; Ludwig Maximilian University, Munich, Germany

  ⨯
• Armin Giese,

  Affiliation Center for Neuropathology and Prion Research; Ludwig Maximilian University, Munich, Germany

  ⨯
• Andrea Zall,

  Affiliation Clemens Schöpf Institute of Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany

  ⨯
• Boris Schmidt,

  Affiliation Clemens Schöpf Institute of Chemistry and Biochemistry, Technische Universität Darmstadt, Darmstadt, Germany

  ⨯
• Aleksandra Szybinska,

  Affiliation Laboratory of Neurodegeneration, International Institute of Molecular and Cell Biology, Warsaw, Poland

  ⨯
• Jacek Kuznicki,

  Affiliation Laboratory of Neurodegeneration, International Institute of Molecular and Cell Biology, Warsaw, Poland

  ⨯
• Jochen Herms

  * E-mail: Jochen.Herms@med.uni-muenchen.de

  Affiliations Department of Translational Brain Research, DZNE – German Center for Neurodegenerative Diseases, Munich, Germany, Center for Neuropathology and Prion Research; Ludwig Maximilian University, Munich, Germany, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany

  ⨯